data_2rps_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rps _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.701 0.286 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.4 m . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.779 0.323 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.673 0.273 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.403 ' CD2' ' CG1' ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.842 0.353 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.687 0.28 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.402 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.467 0.175 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.61 0.243 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.609 0.242 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.649 0.261 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.701 0.286 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.7 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.811 0.339 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.669 0.271 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.775 0.321 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' MET . . . . . 0.409 ' HB2' ' CB ' ' A' ' 7' ' ' CYS . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.837 0.351 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.15 91.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -162.2 168.41 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.5 tt -76.37 -32.61 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.7 -77.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 61.87 120.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.19 72.18 79.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.5 151.37 43.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.6 t -65.13 79.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.1 t -130.51 31.88 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.73 147.24 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.63 110.2 3.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.602 2.201 . . . . 0.0 112.318 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.0 -176.65 2.2 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.474 2.116 . . . . 0.0 112.28 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -60.84 118.8 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.17 108.86 1.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.5 -177.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.467 2.111 . . . . 0.0 112.332 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.54 31.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m 62.45 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.044 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.957 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -86.55 146.3 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.42 72.63 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.8 pt -66.01 -29.85 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.215 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.59 85.26 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.65 143.3 43.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.4 m -101.95 85.49 0.7 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.0 mm-40 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.03 148.92 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 76.02 7.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -137.07 36.35 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 3.4 mt-10 -71.09 -52.56 9.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 61.4 Cg_exo -51.41 151.36 13.66 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.0 130.6 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.5 2.133 . . . . 0.0 112.268 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.13 76.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.52 139.65 35.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.45 -28.17 7.11 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.56 2.173 . . . . 0.0 112.415 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -88.05 -28.67 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m 62.43 78.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.907 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.5 150.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -76.09 121.63 23.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.3 mp -103.94 31.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -177.42 73.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.48 135.33 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m -79.94 162.62 61.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.403 ' CD2' ' CG1' ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.403 ' CG1' ' CD2' ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 100.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 m -160.04 30.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -69.99 111.71 10.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.787 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.54 111.3 3.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.427 2.085 . . . . 0.0 112.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.13 163.4 27.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.529 2.153 . . . . 0.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 54.0 t80 59.97 157.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -86.99 171.76 9.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.83 -168.32 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.615 2.21 . . . . 0.0 112.405 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -58.92 -31.54 68.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.5 132.74 45.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.854 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.773 0.321 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -151.73 155.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -78.99 117.44 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.89 30.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.1 45.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -84.16 159.78 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m -133.76 66.24 72.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 140.89 58.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.6 t -85.83 56.76 4.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.23 31.52 6.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp0 -64.46 -46.72 77.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 81.3 Cg_exo -48.01 103.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.38 2.053 . . . . 0.0 112.552 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.98 -160.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.543 2.162 . . . . 0.0 112.284 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.408 ' CE2' ' HG2' ' A' ' 29' ' ' PRO . 1.3 t80 -87.44 114.84 24.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -59.95 -52.98 69.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 60.5 Cg_exo -51.48 93.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.589 2.192 . . . . 0.0 112.262 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -87.34 -32.95 19.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -171.95 35.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.895 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.817 0.341 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.1 p -81.13 158.33 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.108 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -151.02 169.43 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.796 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 17.5 mt -135.88 31.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.144 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.3 mt -94.21 -32.44 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.14 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -139.39 66.22 36.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.89 128.62 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -90.13 50.05 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.2 t -160.03 60.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -74.79 -61.12 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.412 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 60.6 Cg_endo -72.74 109.49 2.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.667 2.245 . . . . 0.0 112.4 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_exo -71.44 -159.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.683 2.255 . . . . 0.0 112.123 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.4 t80 56.82 103.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.042 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.95 150.98 84.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 172.02 16.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 57.31 77.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -107.7 -179.69 3.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.865 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.826 0.346 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.75 91.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 114.98 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.12 -16.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.286 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 27.1 mt -147.69 -62.27 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 111.058 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 61.28 113.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -91.51 163.09 29.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -74.4 143.19 44.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.2 t -64.0 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.31 41.74 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.406 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -56.75 -60.9 7.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.079 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.406 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 54.5 Cg_endo -69.66 111.81 2.89 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.1 -176.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.108 . . . . 0.0 112.278 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.17 174.48 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.89 161.24 9.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.91 -60.87 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.548 2.165 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -143.67 28.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m 57.91 70.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -60.68 158.31 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -59.37 102.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 3.7 mt -124.19 42.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 mp -80.2 -63.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 57.42 91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.115 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.402 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m -142.34 64.89 17.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.402 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.414 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -89.69 104.38 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.78 93.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -98.57 32.01 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 144.55 98.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.755 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.72 110.47 2.9 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.511 2.14 . . . . 0.0 112.392 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.49 -168.71 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.406 2.071 . . . . 0.0 112.228 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -64.98 86.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.03 164.53 3.32 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.99 -61.63 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 t70 57.66 78.09 0.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -60.25 122.6 14.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 31' ' ' SER . 47.7 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.351 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 17.4 t -86.91 159.3 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.84 -168.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pt -66.46 -14.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.0 tp -82.7 57.89 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -96.9 32.0 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m -116.41 79.9 9.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.43 121.88 28.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 39.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -160.16 31.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -74.75 -60.9 1.18 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 61.2 Cg_endo -73.4 153.43 50.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.55 179.33 4.73 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.01 34.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -83.88 -52.51 0.57 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.4 Cg_exo -54.47 -170.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 112.27 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -159.61 -44.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.73 115.15 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.733 0.302 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -86.3 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 101.13 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.5 tp -110.59 -24.91 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.217 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -119.37 73.45 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -68.19 69.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.37 82.1 3.12 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.7 132.41 45.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.17 80.23 7.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.02 68.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -55.89 129.05 71.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.65 146.67 5.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.6 2.2 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.81 -167.92 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.112 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.93 -178.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.02 148.28 37.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 57.7 Cg_endo -71.52 -173.99 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.58 2.187 . . . . 0.0 112.254 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.19 -43.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 t -102.8 -36.77 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 29' ' ' PRO . 49.1 p90 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.97 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.754 0.312 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 73.0 t 59.36 158.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -90.85 -170.15 2.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -138.85 55.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.99 30.38 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.044 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 58.79 163.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.412 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m -89.04 101.99 3.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.94 149.01 24.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.96 87.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 31.85 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.4 143.53 88.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 110.38 3.06 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.599 2.199 . . . . 0.0 112.398 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.78 139.12 27.28 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.195 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -176.58 40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -68.84 -52.77 16.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 50.0 Cg_exo -53.51 160.44 5.16 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.228 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -176.75 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 22.2 t -88.02 54.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -178.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -170.61 60.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.75 -20.36 48.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.245 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -71.42 105.27 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.938 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.74 85.32 14.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.66 100.03 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.7 100.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.97 30.26 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -85.97 -62.51 0.24 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.408 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 74.2 Cg_endo -77.09 153.42 32.17 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.395 2.063 . . . . 0.0 112.323 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.62 -175.74 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.44 2.093 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.64 -177.03 3.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -55.27 -60.5 8.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -71.9 -168.27 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.518 2.145 . . . . 0.0 112.262 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.03 -41.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -178.36 -38.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t 52.21 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.247 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -93.32 -168.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.3 mt -98.17 32.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -178.34 100.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -78.45 61.02 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m -154.38 86.84 3.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' CD1' ' CG2' ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.63 105.46 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.69 89.83 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.9 t -125.77 44.09 2.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -56.69 109.07 1.45 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.6 153.1 49.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.307 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.45 -167.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.276 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 171.64 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.805 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.431 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.5 m-20 -59.49 -59.03 15.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.992 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.431 ' HD3' ' CB ' ' A' ' 28' ' ' ASP . 85.3 Cg_exo -46.6 171.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.407 2.071 . . . . 0.0 112.412 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -148.38 -70.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.1 78.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.907 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -80.94 149.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.79 163.09 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -63.96 -28.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.211 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.4 -79.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 58.43 163.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.77 112.72 31.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.42 163.26 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -90.21 45.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -129.27 66.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.659 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -50.49 176.38 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.178 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 77.4 Cg_exo -50.14 -179.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.626 2.218 . . . . 0.0 112.472 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.68 174.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.559 2.173 . . . . 0.0 112.403 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -106.32 171.04 7.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.51 147.65 68.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.73 -47.84 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p30 43.29 32.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.427 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.81 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.919 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.6 119.74 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -88.01 168.56 12.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tt -94.42 -26.5 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.26 95.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -51.98 173.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.76 74.8 70.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.65 136.51 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.18 46.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 t -160.11 43.59 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.408 ' CB ' ' HD3' ' A' ' 25' ' ' PRO . 1.3 mt-10 -80.42 -52.76 0.93 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 26' ' ' PRO . 31.2 Cg_exo -57.74 -47.88 19.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.337 2.025 . . . . 0.0 112.361 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 25' ' ' PRO . 86.9 Cg_endo -82.75 -167.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.569 2.179 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 t80 58.69 108.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.47 173.94 3.02 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.39 -175.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.299 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -79.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.8 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.4 64.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.442 . . . . 0.0 111.031 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 108.93 8.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -112.82 33.06 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.025 0.44 . . . . 0.0 110.993 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 mp -140.33 -46.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 152.53 40.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m -120.58 81.52 32.21 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.57 105.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.0 t -90.35 37.94 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -159.97 71.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -100.09 105.62 36.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 52.6 Cg_exo -52.88 -47.0 29.8 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 112.61 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 78.3 Cg_endo -77.79 145.4 22.73 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 112.46 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -176.78 179.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -118.77 63.75 5.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -168.02 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.602 2.202 . . . . 0.0 112.316 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -120.13 30.48 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 -170.05 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.36 125.0 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.63 127.93 34.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tt -109.86 -24.02 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.41 -45.66 92.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.91 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 56.28 55.54 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.3 m -151.66 84.23 5.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.867 -179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.09 35.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -65.48 99.74 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m -140.03 31.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.2 mt-10 -72.39 -65.02 0.84 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -42.62 -57.23 1.75 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.92 2.413 . . . . 0.0 112.722 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 41.7 Cg_endo -67.34 -171.03 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.365 2.043 . . . . 0.0 112.314 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -174.37 4.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 m-20 -68.38 -62.55 2.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 18.0 Cg_endo -60.43 -75.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.413 2.075 . . . . 0.0 112.314 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -177.81 -70.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -176.47 -78.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.84 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.879 0.371 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.3 p -67.93 159.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -54.21 -177.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.076 -179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.4 tt -142.83 58.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.404 ' N ' HD21 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -65.94 -13.62 60.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.644 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.59 105.98 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 13.7 m -158.99 61.61 1.92 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.677 179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -79.84 79.67 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.74 82.78 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.04 59.9 4.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.13 94.22 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.33 171.6 11.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.454 2.103 . . . . 0.0 112.265 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.59 -168.8 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.566 2.177 . . . . 0.0 112.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.99 142.96 52.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.58 155.12 30.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.16 99.05 1.14 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -96.51 62.06 2.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.32 32.47 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.009 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.799 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -144.92 33.24 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.069 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -60.27 -169.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 mt -113.52 31.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.98 46.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -174.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.2 66.64 60.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' CD2' ' HB ' ' A' ' 20' ' ' VAL . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.404 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.82 141.87 32.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.4 m -58.36 91.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.024 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.23 30.69 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.788 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -76.57 -60.9 0.82 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 61.4 Cg_endo -73.36 110.22 3.01 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.48 2.12 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -68.25 -167.24 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.325 2.017 . . . . 0.0 112.307 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -66.42 75.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.21 110.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.91 91.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.409 2.072 . . . . 0.0 112.437 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.33 -36.64 19.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -178.15 -76.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.958 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.75 0.31 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 10.2 p -76.05 109.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -104.19 30.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.092 179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.4 pp -158.94 31.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -59.21 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m -122.25 77.33 43.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -70.13 134.84 48.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.1 t -66.98 99.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 29.95 5.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.9 148.65 57.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.87 112.01 3.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.577 2.184 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.09 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.372 2.048 . . . . 0.0 112.306 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.07 29.71 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -89.59 -62.72 0.21 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 75.2 Cg_endo -77.45 169.96 20.19 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.322 2.014 . . . . 0.0 112.304 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.92 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.88 -39.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.83 128.03 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -60.16 -177.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.43 31.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.179 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tp -159.83 28.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 161.58 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.409 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m -94.81 153.49 40.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.857 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.409 ' HB2' ' CB ' ' A' ' 7' ' ' CYS . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.08 127.11 29.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -90.36 26.99 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 t -160.22 35.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.695 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 2.4 mt-10 -55.79 -61.02 7.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.318 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 56.2 Cg_endo -70.86 110.94 2.91 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.429 2.086 . . . . 0.0 112.398 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.64 130.22 10.56 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.478 2.118 . . . . 0.0 112.214 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.18 97.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -61.15 -52.5 71.04 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.2 Cg_exo -52.82 89.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 112.219 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.9 36.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -162.86 35.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.954 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.701 0.286 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.676 HD11 ' CG2' ' A' ' 20' ' ' VAL . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 37.4 m . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.779 0.323 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.823 HD21 ' CG1' ' A' ' 20' ' ' VAL . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HB2' HD12 ' A' ' 14' ' ' LEU . 13.4 mm100 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.823 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.673 0.273 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.907 HD21 HG11 ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.907 HG11 HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.842 0.353 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD11 ' CG2' ' A' ' 20' ' ' VAL . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 14' ' ' LEU . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.687 0.28 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' CG1' ' A' ' 20' ' ' VAL . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.675 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.516 ' O ' HD23 ' A' ' 14' ' ' LEU . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.852 HD11 ' CG1' ' A' ' 20' ' ' VAL . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.852 ' CG1' HD11 ' A' ' 14' ' ' LEU . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 20' ' ' VAL . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.467 0.175 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 ' CG1' ' A' ' 20' ' ' VAL . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.969 HD22 HG23 ' A' ' 20' ' ' VAL . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 14' ' ' LEU . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.55 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD22 ' A' ' 14' ' ' LEU . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.61 0.243 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.609 HD11 HG21 ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.609 0.242 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.684 HD11 ' CG2' ' A' ' 20' ' ' VAL . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.684 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.536 HD21 ' CG1' ' A' ' 20' ' ' VAL . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.649 0.261 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.792 HD11 HG23 ' A' ' 20' ' ' VAL . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.792 HG23 HD11 ' A' ' 14' ' ' LEU . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.701 0.286 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.67 ' CD2' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' A' ' 14' ' ' LEU . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.811 0.339 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 20' ' ' VAL . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.737 HD12 ' CB ' ' A' ' 18' ' ' GLN . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.737 ' CB ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 21' ' ' ALA . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.669 0.271 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.942 HD22 HG23 ' A' ' 20' ' ' VAL . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 14' ' ' LEU . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG23 HD22 ' A' ' 14' ' ' LEU . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.775 0.321 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.844 ' HB2' HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' A' ' 14' ' ' LEU . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 20' ' ' VAL . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.837 0.351 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.15 91.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -162.2 168.41 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.69 HG23 HD12 ' A' ' 5' ' ' LEU . 2.5 tt -76.37 -32.61 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.69 HD12 HG23 ' A' ' 4' ' ' ILE . 7.9 mp -74.7 -77.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 61.87 120.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.19 72.18 79.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.676 HD11 ' CG2' ' A' ' 20' ' ' VAL . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' THR . . . -71.5 151.37 43.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 22' ' ' THR . 6.6 t -65.13 79.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 21' ' ' ALA . 5.1 t -130.51 31.88 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.73 147.24 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.63 110.2 3.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.602 2.201 . . . . 0.0 112.318 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.0 -176.65 2.2 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.474 2.116 . . . . 0.0 112.28 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -60.84 118.8 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.17 108.86 1.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.5 -177.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.467 2.111 . . . . 0.0 112.332 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.54 31.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m 62.45 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.044 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.957 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.703 HG13 HG23 ' A' ' 4' ' ' ILE . 11.2 p -86.55 146.3 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.42 72.63 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.703 HG23 HG13 ' A' ' 2' ' ' VAL . 1.8 pt -66.01 -29.85 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.59 85.26 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.65 143.3 43.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 37.4 m -101.95 85.49 0.7 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.823 HD21 ' CG1' ' A' ' 20' ' ' VAL . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HB2' HD12 ' A' ' 14' ' ' LEU . 13.4 mm100 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.823 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.03 148.92 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 76.02 7.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -137.07 36.35 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 3.4 mt-10 -71.09 -52.56 9.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 61.4 Cg_exo -51.41 151.36 13.66 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.0 130.6 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.5 2.133 . . . . 0.0 112.268 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.13 76.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.52 139.65 35.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.45 -28.17 7.11 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.56 2.173 . . . . 0.0 112.415 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -88.05 -28.67 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m 62.43 78.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.907 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.5 150.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -76.09 121.63 23.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.582 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.3 mp -103.94 31.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -177.42 73.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.48 135.33 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m -79.94 162.62 61.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG3' HG21 ' A' ' 22' ' ' THR . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.907 HD21 HG11 ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.907 HG11 HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 100.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.4 HG21 ' HG3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.452 ' O ' HG22 ' A' ' 23' ' ' THR . 9.8 m -160.04 30.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -69.99 111.71 10.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.787 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.54 111.3 3.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.427 2.085 . . . . 0.0 112.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.13 163.4 27.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.529 2.153 . . . . 0.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 54.0 t80 59.97 157.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -86.99 171.76 9.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.83 -168.32 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.615 2.21 . . . . 0.0 112.405 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -58.92 -31.54 68.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.5 132.74 45.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.854 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.773 0.321 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' GLN . 21.4 t -151.73 155.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 4.8 tt0 -78.99 117.44 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.89 30.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.1 45.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -84.16 159.78 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m -133.76 66.24 72.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 22' ' ' THR . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD11 ' CG2' ' A' ' 20' ' ' VAL . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 14' ' ' LEU . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 140.89 58.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 22' ' ' THR . 10.6 t -85.83 56.76 4.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.23 31.52 6.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp0 -64.46 -46.72 77.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 81.3 Cg_exo -48.01 103.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.38 2.053 . . . . 0.0 112.552 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.98 -160.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.543 2.162 . . . . 0.0 112.284 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -87.44 114.84 24.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -59.95 -52.98 69.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 60.5 Cg_exo -51.48 93.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.589 2.192 . . . . 0.0 112.262 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -87.34 -32.95 19.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -171.95 35.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.895 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.817 0.341 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.1 p -81.13 158.33 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.108 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.4 mm-40 -151.02 169.43 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 4' ' ' ILE . 17.5 mt -135.88 31.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.144 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 5' ' ' LEU . 13.3 mt -94.21 -32.44 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.14 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -139.39 66.22 36.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.89 128.62 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -90.13 50.05 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.2 t -160.03 60.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -74.79 -61.12 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 Cg_endo -72.74 109.49 2.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.667 2.245 . . . . 0.0 112.4 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 10.2 Cg_exo -71.44 -159.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.683 2.255 . . . . 0.0 112.123 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.4 t80 56.82 103.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.042 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.95 150.98 84.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 172.02 16.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 57.31 77.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -107.7 -179.69 3.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.865 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.826 0.346 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.75 91.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 114.98 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.733 HG23 ' HG ' ' A' ' 5' ' ' LEU . 7.6 tp -111.12 -16.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.286 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' HG ' HG23 ' A' ' 4' ' ' ILE . 27.1 mt -147.69 -62.27 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 111.058 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 61.28 113.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -91.51 163.09 29.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' CG1' ' A' ' 20' ' ' VAL . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.675 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -74.4 143.19 44.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' THR . 3.2 t -64.0 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.31 41.74 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -56.75 -60.9 7.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.079 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 24' ' ' GLU . 54.5 Cg_endo -69.66 111.81 2.89 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.1 -176.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.108 . . . . 0.0 112.278 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.17 174.48 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.89 161.24 9.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.91 -60.87 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.548 2.165 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -143.67 28.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m 57.91 70.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.2 p -60.68 158.31 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.7 pt20 -59.37 102.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.7 mt -124.19 42.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.549 HD12 ' H ' ' A' ' 5' ' ' LEU . 2.2 mp -80.2 -63.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 57.42 91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.115 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m -142.34 64.89 17.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.516 ' O ' HD23 ' A' ' 14' ' ' LEU . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.852 HD11 ' CG1' ' A' ' 20' ' ' VAL . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.852 ' CG1' HD11 ' A' ' 14' ' ' LEU . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -89.69 104.38 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.78 93.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -98.57 32.01 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 144.55 98.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.755 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.72 110.47 2.9 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.511 2.14 . . . . 0.0 112.392 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.49 -168.71 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.406 2.071 . . . . 0.0 112.228 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -64.98 86.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.03 164.53 3.32 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.99 -61.63 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 t70 57.66 78.09 0.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -60.25 122.6 14.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 31' ' ' SER . 47.7 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.351 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' GLN . 17.4 t -86.91 159.3 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -105.84 -168.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pt -66.46 -14.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' A' ' 13' ' ' MET . 7.0 tp -82.7 57.89 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' CD ' HG11 ' A' ' 2' ' ' VAL . 5.8 mmt180 -96.9 32.0 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m -116.41 79.9 9.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.462 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.43 121.88 28.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 39.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -160.16 31.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -74.75 -60.9 1.18 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 61.2 Cg_endo -73.4 153.43 50.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.55 179.33 4.73 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.01 34.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -83.88 -52.51 0.57 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.4 Cg_exo -54.47 -170.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 112.27 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -159.61 -44.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.73 115.15 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.733 0.302 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -86.3 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 101.13 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG23 HD23 ' A' ' 5' ' ' LEU . 8.5 tp -110.59 -24.91 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.217 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -119.37 73.45 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -68.19 69.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.37 82.1 3.12 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 20' ' ' VAL . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.7 132.41 45.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.17 80.23 7.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.02 68.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -55.89 129.05 71.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.65 146.67 5.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.6 2.2 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.81 -167.92 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.112 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.93 -178.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.02 148.28 37.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 57.7 Cg_endo -71.52 -173.99 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.58 2.187 . . . . 0.0 112.254 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.19 -43.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 t -102.8 -36.77 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 29' ' ' PRO . 49.1 p90 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.97 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.754 0.312 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' GLN . 73.0 t 59.36 158.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.8 mp0 -90.85 -170.15 2.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -138.85 55.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.99 30.38 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.044 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 58.79 163.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m -89.04 101.99 3.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 ' CG1' ' A' ' 20' ' ' VAL . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -87.94 149.01 24.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.96 87.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 31.85 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.4 143.53 88.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 110.38 3.06 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.599 2.199 . . . . 0.0 112.398 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.78 139.12 27.28 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.195 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -176.58 40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -68.84 -52.77 16.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 50.0 Cg_exo -53.51 160.44 5.16 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.228 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -176.75 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 2' ' ' VAL . 22.2 t -88.02 54.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -178.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -170.61 60.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -58.75 -20.36 48.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.245 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.62 ' N ' HD12 ' A' ' 5' ' ' LEU . 13.1 tpt180 -71.42 105.27 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.74 85.32 14.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.969 HD22 HG23 ' A' ' 20' ' ' VAL . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 14' ' ' LEU . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD22 ' A' ' 14' ' ' LEU . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -70.66 100.03 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.7 100.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.97 30.26 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -85.97 -62.51 0.24 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 24' ' ' GLU . 74.2 Cg_endo -77.09 153.42 32.17 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.395 2.063 . . . . 0.0 112.323 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.62 -175.74 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.44 2.093 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.64 -177.03 3.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 4.4 m-20 -55.27 -60.5 8.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 28' ' ' ASP . 58.5 Cg_endo -71.9 -168.27 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.518 2.145 . . . . 0.0 112.262 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.03 -41.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -178.36 -38.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t 52.21 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.247 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -93.32 -168.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.593 ' O ' HG22 ' A' ' 4' ' ' ILE . 2.3 mt -98.17 32.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -178.34 100.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -78.45 61.02 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m -154.38 86.84 3.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.609 HD11 HG21 ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -68.63 105.46 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.69 89.83 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.9 t -125.77 44.09 2.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -56.69 109.07 1.45 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.6 153.1 49.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.307 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.45 -167.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.276 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 171.64 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.805 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.5 m-20 -59.49 -59.03 15.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.992 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' A' ' 28' ' ' ASP . 85.3 Cg_exo -46.6 171.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.407 2.071 . . . . 0.0 112.412 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -148.38 -70.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.1 78.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.907 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -80.94 149.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.79 163.09 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -63.96 -28.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.211 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.4 -79.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 58.43 163.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.77 112.72 31.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.684 HD11 ' CG2' ' A' ' 20' ' ' VAL . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.684 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -88.42 163.26 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -90.21 45.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.447 ' O ' HG23 ' A' ' 23' ' ' THR . 7.3 t -129.27 66.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.659 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -50.49 176.38 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.178 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 77.4 Cg_exo -50.14 -179.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.626 2.218 . . . . 0.0 112.472 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.68 174.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.559 2.173 . . . . 0.0 112.403 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -106.32 171.04 7.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.51 147.65 68.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.73 -47.84 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p30 43.29 32.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.427 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.81 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.919 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.6 119.74 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -88.01 168.56 12.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tt -94.42 -26.5 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.26 95.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -51.98 173.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.76 74.8 70.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.536 HD21 ' CG1' ' A' ' 20' ' ' VAL . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -68.65 136.51 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.18 46.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 t -160.11 43.59 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HD3' ' A' ' 25' ' ' PRO . 1.3 mt-10 -80.42 -52.76 0.93 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 26' ' ' PRO . 31.2 Cg_exo -57.74 -47.88 19.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.337 2.025 . . . . 0.0 112.361 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 25' ' ' PRO . 86.9 Cg_endo -82.75 -167.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.569 2.179 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 t80 58.69 108.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.47 173.94 3.02 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.39 -175.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.299 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -79.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.8 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.567 ' O ' HG13 ' A' ' 2' ' ' VAL . 9.8 p -73.4 64.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.442 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 108.93 8.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' CD1' ' A' ' 5' ' ' LEU . 1.1 pp -112.82 33.06 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.025 0.44 . . . . 0.0 110.993 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.806 ' CD1' HD12 ' A' ' 4' ' ' ILE . 1.8 mp -140.33 -46.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 152.53 40.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m -120.58 81.52 32.21 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLN . . . . . 0.753 ' NE2' HG21 ' A' ' 22' ' ' THR . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.792 HD11 HG23 ' A' ' 20' ' ' VAL . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.792 HG23 HD11 ' A' ' 14' ' ' LEU . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -64.57 105.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.753 HG21 ' NE2' ' A' ' 12' ' ' GLN . 9.0 t -90.35 37.94 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -159.97 71.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -100.09 105.62 36.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 52.6 Cg_exo -52.88 -47.0 29.8 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 112.61 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 78.3 Cg_endo -77.79 145.4 22.73 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 112.46 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -176.78 179.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -118.77 63.75 5.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -168.02 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.602 2.202 . . . . 0.0 112.316 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -120.13 30.48 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 -170.05 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.36 125.0 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.63 127.93 34.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tt -109.86 -24.02 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -60.41 -45.66 92.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.91 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 56.28 55.54 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD12 ' A' ' 5' ' ' LEU . 93.3 m -151.66 84.23 5.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.867 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' CD2' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' A' ' 14' ' ' LEU . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.09 35.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -65.48 99.74 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m -140.03 31.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.2 mt-10 -72.39 -65.02 0.84 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -42.62 -57.23 1.75 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.92 2.413 . . . . 0.0 112.722 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 41.7 Cg_endo -67.34 -171.03 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.365 2.043 . . . . 0.0 112.314 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -174.37 4.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 m-20 -68.38 -62.55 2.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 18.0 Cg_endo -60.43 -75.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.413 2.075 . . . . 0.0 112.314 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -177.81 -70.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -176.47 -78.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.84 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.879 0.371 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.3 p -67.93 159.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -54.21 -177.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.076 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.4 tt -142.83 58.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.689 HD13 ' H ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -65.94 -13.62 60.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.644 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -174.59 105.98 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 m -158.99 61.61 1.92 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.677 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 20' ' ' VAL . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' O ' HG11 ' A' ' 2' ' ' VAL . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -79.84 79.67 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.74 82.78 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.04 59.9 4.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.13 94.22 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.33 171.6 11.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.454 2.103 . . . . 0.0 112.265 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.59 -168.8 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.566 2.177 . . . . 0.0 112.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.99 142.96 52.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.58 155.12 30.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.16 99.05 1.14 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -96.51 62.06 2.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.32 32.47 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.009 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.799 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 2' ' ' VAL . 16.8 t -144.92 33.24 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -60.27 -169.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.591 ' O ' HG22 ' A' ' 4' ' ' ILE . 2.2 mt -113.52 31.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.98 46.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -174.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.2 66.64 60.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.737 HD12 ' CB ' ' A' ' 18' ' ' GLN . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.737 ' CB ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 21' ' ' ALA . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -99.82 141.87 32.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.4 m -58.36 91.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.024 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.23 30.69 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.788 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -76.57 -60.9 0.82 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 61.4 Cg_endo -73.36 110.22 3.01 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.48 2.12 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 45.2 Cg_endo -68.25 -167.24 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.325 2.017 . . . . 0.0 112.307 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -66.42 75.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.21 110.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.91 91.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.409 2.072 . . . . 0.0 112.437 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.33 -36.64 19.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -178.15 -76.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.958 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.75 0.31 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 2' ' ' VAL . 10.2 p -76.05 109.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' OE1' HD11 ' A' ' 5' ' ' LEU . 2.9 tt0 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 5' ' ' LEU . 1.2 pp -104.19 30.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.092 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.653 HD13 ' OE1' ' A' ' 18' ' ' GLN . 1.4 pp -158.94 31.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -59.21 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m -122.25 77.33 43.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 22' ' ' THR . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.942 HD22 HG23 ' A' ' 20' ' ' VAL . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 14' ' ' LEU . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 14' ' ' LEU . 1.0 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG23 HD22 ' A' ' 14' ' ' LEU . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -70.13 134.84 48.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' THR . 10.1 t -66.98 99.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 29.95 5.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.9 148.65 57.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.87 112.01 3.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.577 2.184 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.09 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.372 2.048 . . . . 0.0 112.306 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.07 29.71 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -89.59 -62.72 0.21 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 28' ' ' ASP . 75.2 Cg_endo -77.45 169.96 20.19 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.322 2.014 . . . . 0.0 112.304 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.92 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.88 -39.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.83 128.03 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -60.16 -177.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.43 31.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.179 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tp -159.83 28.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 161.58 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m -94.81 153.49 40.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.857 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.844 ' HB2' HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' A' ' 14' ' ' LEU . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 20' ' ' VAL . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -63.08 127.11 29.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -90.36 26.99 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 t -160.22 35.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.695 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 2.4 mt-10 -55.79 -61.02 7.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.318 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 56.2 Cg_endo -70.86 110.94 2.91 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.429 2.086 . . . . 0.0 112.398 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.64 130.22 10.56 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.478 2.118 . . . . 0.0 112.214 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.18 97.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -61.15 -52.5 71.04 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.2 Cg_exo -52.82 89.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 112.219 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.9 36.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -162.86 35.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.954 179.96 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 CA--C 1.529 0.154 0 CA-C-O 120.701 0.286 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.676 HD11 ' CG2' ' A' ' 20' ' ' VAL . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 37.4 m . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.779 0.323 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.823 HD21 ' CG1' ' A' ' 20' ' ' VAL . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HB2' HD12 ' A' ' 14' ' ' LEU . 8.0 mm-40 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.823 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.673 0.273 . . . . 0.0 110.825 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.907 HD21 HG11 ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.907 HG11 HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m . . . . . 0 CA--C 1.528 0.12 0 CA-C-O 120.842 0.353 . . . . 0.0 110.801 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.658 HD11 ' CG2' ' A' ' 20' ' ' VAL . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 14' ' ' LEU . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.882 0.372 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.456 -0.138 0 CA-C-O 120.687 0.28 . . . . 0.0 110.993 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' CG1' ' A' ' 20' ' ' VAL . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.675 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.804 0.335 . . . . 0.0 110.888 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.516 ' O ' HD23 ' A' ' 14' ' ' LEU . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.852 HD11 ' CG1' ' A' ' 20' ' ' VAL . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.852 ' CG1' HD11 ' A' ' 14' ' ' LEU . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.74 0.305 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.817 0.341 . . . . 0.0 110.82 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 20' ' ' VAL . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m . . . . . 0 CA--C 1.53 0.183 0 CA-C-O 120.467 0.175 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 ' CG1' ' A' ' 20' ' ' VAL . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.233 0.188 0 CA-C-O 120.745 0.307 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.969 HD22 HG23 ' A' ' 20' ' ' VAL . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 14' ' ' LEU . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.55 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD22 ' A' ' 14' ' ' LEU . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.61 0.243 . . . . 0.0 110.747 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.609 HD11 HG21 ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.53 0.202 0 CA-C-O 120.609 0.242 . . . . 0.0 110.967 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.684 HD11 ' CG2' ' A' ' 20' ' ' VAL . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.684 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m . . . . . 0 CA--C 1.527 0.095 0 CA-C-O 120.859 0.361 . . . . 0.0 110.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.536 HD21 ' CG1' ' A' ' 20' ' ' VAL . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.649 0.261 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.792 HD11 HG23 ' A' ' 20' ' ' VAL . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.792 HG23 HD11 ' A' ' 14' ' ' LEU . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 93.3 m . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.701 0.286 . . . . 0.0 110.867 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.67 ' CD2' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' A' ' 14' ' ' LEU . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 m . . . . . 0 CA--C 1.529 0.162 0 CA-C-O 120.811 0.339 . . . . 0.0 110.677 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 20' ' ' VAL . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.529 0.159 0 CA-C-O 120.837 0.351 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.737 HD12 ' CB ' ' A' ' 18' ' ' GLN . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.737 ' CB ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 21' ' ' ALA . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m . . . . . 0 CA--C 1.527 0.094 0 CA-C-O 120.669 0.271 . . . . 0.0 111.078 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.942 HD22 HG23 ' A' ' 20' ' ' VAL . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 14' ' ' LEU . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.712 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.942 HG23 HD22 ' A' ' 14' ' ' LEU . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 20' ' ' VAL . . . . . . . . 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.431 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m . . . . . 0 N--CA 1.456 -0.17 0 CA-C-O 120.775 0.321 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.844 ' HB2' HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' A' ' 14' ' ' LEU . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 20' ' ' VAL . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . . . . . . 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.399 0 CA-C-O 120.837 0.351 . . . . 0.0 111.225 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.4 t -87.15 91.22 3.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.3 pm0 -162.2 168.41 22.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.935 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.69 HG23 HD12 ' A' ' 5' ' ' LEU . 2.5 tt -76.37 -32.61 22.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.088 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.69 HD12 HG23 ' A' ' 4' ' ' ILE . 7.9 mp -74.7 -77.08 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.879 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 3.0 ttp180 61.87 120.7 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.951 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.5 m -128.19 72.18 79.61 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.905 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.4 -164.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.566 2.177 . . . . 0.0 112.285 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 -57.44 123.82 16.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.951 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 119.11 -28.28 6.68 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.455 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.7 mtt -101.62 107.38 18.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.914 0.388 . . . . 0.0 110.875 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.95 124.46 34.26 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.918 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.7 ttt -86.88 143.23 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.902 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.676 HD11 ' CG2' ' A' ' 20' ' ' VAL . 9.6 mt -101.97 164.72 11.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -59.6 -31.42 69.46 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -33.73 71.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.917 -179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.6 -28.4 3.99 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.525 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -60.11 148.01 37.5 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -109.53 112.52 24.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.89 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.676 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.0 t -91.93 101.07 12.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.163 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' THR . . . -71.5 151.37 43.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.13 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.515 HG23 ' O ' ' A' ' 22' ' ' THR . 6.6 t -65.13 79.62 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.936 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.424 HG22 ' O ' ' A' ' 21' ' ' ALA . 5.1 t -130.51 31.88 4.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.936 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -77.73 147.24 74.16 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.826 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -73.63 110.2 3.02 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.602 2.201 . . . . 0.0 112.318 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.0 -176.65 2.2 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.474 2.116 . . . . 0.0 112.28 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.2 p90 -60.84 118.8 7.12 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.945 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -56.17 108.86 1.33 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.964 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -51.5 -177.79 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.467 2.111 . . . . 0.0 112.332 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -144.54 31.0 1.2 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.963 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 55.7 m 62.45 -81.06 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.044 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.251 -0.881 . . . . 0.0 110.957 179.963 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.2 m . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.824 0.345 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.703 HG13 HG23 ' A' ' 4' ' ' ILE . 11.2 p -86.55 146.3 6.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.012 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -69.42 72.63 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.703 HG23 HG13 ' A' ' 2' ' ' VAL . 1.8 pt -66.01 -29.85 48.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.215 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -145.59 85.26 1.7 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.883 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -136.65 143.3 43.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 37.4 m -101.95 85.49 0.7 Allowed Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.857 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.403 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.0 Cg_endo -56.61 -164.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 122.55 2.167 . . . . 0.0 112.422 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -60.48 116.32 4.23 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.898 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.79 -28.67 5.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.481 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -114.35 127.01 55.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.89 0.376 . . . . 0.0 110.88 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -123.94 128.29 49.21 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.83 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.7 ptp -63.89 149.25 47.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.933 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.823 HD21 ' CG1' ' A' ' 20' ' ' VAL . 5.7 mt -103.92 168.67 8.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.907 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 14.4 ptp180 -60.22 -31.22 69.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.841 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.2 m -70.9 -33.0 70.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.832 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -28.9 3.53 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.468 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.567 ' HB2' HD12 ' A' ' 14' ' ' LEU . 8.0 mm-40 -63.84 -176.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.779 0.323 . . . . 0.0 110.932 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -135.9 112.89 10.34 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.924 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.823 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.2 p -100.06 146.93 8.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.03 148.92 25.08 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.02 76.02 7.06 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.842 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.8 t -137.07 36.35 2.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.909 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 3.4 mt-10 -71.09 -52.56 9.25 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.024 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 61.4 Cg_exo -51.41 151.36 13.66 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.446 2.097 . . . . 0.0 112.371 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -73.0 130.6 15.7 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.5 2.133 . . . . 0.0 112.268 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -103.13 76.04 1.42 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.52 139.65 35.82 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.836 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.45 -28.17 7.11 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.56 2.173 . . . . 0.0 112.415 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 24.2 p30 -88.05 -28.67 21.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.064 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 m 62.43 78.14 0.3 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.873 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.6 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.239 -0.886 . . . . 0.0 110.907 -179.955 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.486 1.348 0 CA-C-O 120.973 0.416 . . . . 0.0 111.211 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 19.8 t -86.5 150.94 3.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.063 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.0 mt-30 -76.09 121.63 23.08 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.842 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.3 mp -103.94 31.04 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.141 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 6.1 tp -177.42 73.67 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.845 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -176.48 135.33 0.24 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.943 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.6 m -79.94 162.62 61.6 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.825 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -51.56 179.12 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.295 0 C-N-CA 122.546 2.164 . . . . 0.0 112.431 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -65.87 116.88 7.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.029 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.16 -21.51 17.57 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.742 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.34 160.49 31.23 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.939 0.399 . . . . 0.0 111.077 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.4 ' HG3' HG21 ' A' ' 22' ' ' THR . 10.7 mm-40 -132.55 145.24 50.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.814 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 1.4 ttt -68.68 126.03 28.42 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.922 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.907 HD21 HG11 ' A' ' 20' ' ' VAL . 58.3 mt -89.42 171.34 9.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 8.9 ttt85 -57.7 -30.92 65.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.008 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.8 m -82.51 -29.68 30.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.851 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.43 -26.6 5.72 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.512 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -62.18 147.02 49.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.847 0.356 . . . . 0.0 110.91 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 51.1 m -87.57 117.29 26.28 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.959 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.907 HG11 HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.99 138.31 24.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.102 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.88 100.75 1.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.042 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.4 HG21 ' HG3' ' A' ' 12' ' ' GLN . 0.9 OUTLIER -89.81 56.94 3.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.934 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 23' ' ' THR . 9.8 m -160.04 30.9 0.18 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.013 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -69.99 111.71 10.07 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.787 179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -73.54 111.3 3.26 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.427 2.085 . . . . 0.0 112.339 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.13 163.4 27.99 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.529 2.153 . . . . 0.0 112.355 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.406 ' CD2' ' O ' ' A' ' 28' ' ' ASP . 54.0 t80 59.97 157.99 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.977 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' O ' ' CD2' ' A' ' 27' ' ' PHE . 0.5 OUTLIER -86.99 171.76 9.4 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.884 -179.941 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -77.83 -168.32 0.59 Allowed 'Trans proline' 0 N--CA 1.464 -0.252 0 C-N-CA 122.615 2.21 . . . . 0.0 112.405 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -58.92 -31.54 68.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.919 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.5 132.74 45.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.848 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.365 -0.826 . . . . 0.0 110.854 179.989 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.342 0 CA-C-O 120.773 0.321 . . . . 0.0 111.189 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 3' ' ' GLN . 21.4 t -151.73 155.43 6.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.2 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.42 ' N ' HG12 ' A' ' 2' ' ' VAL . 4.8 tt0 -78.99 117.44 20.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.93 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -107.89 30.69 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.184 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -153.1 45.69 0.67 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.854 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -84.16 159.78 20.99 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.899 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 51.4 m -133.76 66.24 72.6 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.801 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.69 -169.41 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.591 2.194 . . . . 0.0 112.333 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -58.49 106.26 0.37 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.896 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.406 ' O ' HG22 ' A' ' 22' ' ' THR . . . 141.96 -28.38 2.26 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.457 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.1 mtt -106.64 111.57 24.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.856 0.36 . . . . 0.0 110.848 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -84.32 127.56 34.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.953 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 mtp -76.76 137.07 39.08 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.894 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.658 HD11 ' CG2' ' A' ' 20' ' ' VAL . 67.1 mt -96.9 162.96 13.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.946 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.8 ptm180 -59.07 -30.99 68.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.993 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.0 m -76.68 -31.44 57.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.878 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.46 -27.32 3.77 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.57 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -59.64 171.85 0.8 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.87 0.367 . . . . 0.0 110.999 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -127.14 121.76 32.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.848 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.658 ' CG2' HD11 ' A' ' 14' ' ' LEU . 21.3 t -99.97 118.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.137 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.67 140.89 58.72 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.077 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.487 HG23 ' O ' ' A' ' 22' ' ' THR . 10.6 t -85.83 56.76 4.11 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.882 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -118.23 31.52 6.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.846 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.477 ' N ' ' CD ' ' A' ' 25' ' ' PRO . 1.6 mp0 -64.46 -46.72 77.94 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.29 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 24' ' ' GLU . 81.3 Cg_exo -48.01 103.94 0.06 OUTLIER 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.38 2.053 . . . . 0.0 112.552 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.98 -160.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.543 2.162 . . . . 0.0 112.284 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -87.44 114.84 24.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.846 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -59.95 -52.98 69.74 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.987 179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.414 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 60.5 Cg_exo -51.48 93.13 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.589 2.192 . . . . 0.0 112.262 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 21.2 p-10 -87.34 -32.95 19.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.949 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.2 m -171.95 35.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.6 t80 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.895 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 44.8 p . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.817 0.341 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.1 p -81.13 158.33 4.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.108 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.475 ' N ' HG22 ' A' ' 2' ' ' VAL . 1.4 mm-40 -151.02 169.43 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.796 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.55 HG22 ' O ' ' A' ' 4' ' ' ILE . 17.5 mt -135.88 31.59 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.144 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.429 HD23 ' HA ' ' A' ' 5' ' ' LEU . 13.3 mt -94.21 -32.44 13.69 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.912 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.14 100.95 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.005 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.2 m -139.39 66.22 36.11 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.845 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -55.42 -166.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.678 2.252 . . . . 0.0 112.439 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -55.76 131.68 47.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.32 -29.02 10.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.391 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 72.2 mtp -119.14 111.18 17.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.784 0.326 . . . . 0.0 110.792 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -114.86 144.69 43.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.948 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -80.65 145.81 31.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.899 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.649 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -105.01 -179.04 3.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.899 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -35.67 76.21 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.073 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.649 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.3 m -66.13 -30.2 70.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.98 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.06 -31.68 5.03 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.419 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -60.65 170.42 1.45 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.828 0.347 . . . . 0.0 110.903 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.13 106.55 14.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.2 p -94.54 147.46 5.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -88.89 128.62 35.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.08 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.8 t -90.13 50.05 1.8 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.021 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.2 t -160.03 60.99 0.35 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.852 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -74.79 -61.12 1.13 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.037 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 60.6 Cg_endo -72.74 109.49 2.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.667 2.245 . . . . 0.0 112.4 -179.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 25' ' ' PRO . 10.2 Cg_exo -71.44 -159.46 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.683 2.255 . . . . 0.0 112.123 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 91.4 t80 56.82 103.81 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.042 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -75.95 150.98 84.01 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.861 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -73.4 172.02 16.52 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.597 2.198 . . . . 0.0 112.403 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 57.31 77.57 0.27 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.98 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.8 p -107.7 -179.69 3.98 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.004 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 84.6 t80 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.249 -0.882 . . . . 0.0 110.865 179.904 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 m . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 120.826 0.346 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 16.8 t -149.75 91.73 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.133 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.4 tt0 -82.78 114.98 21.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.847 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.733 HG23 ' HG ' ' A' ' 5' ' ' LEU . 7.6 tp -111.12 -16.69 8.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.286 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.733 ' HG ' HG23 ' A' ' 4' ' ' ILE . 27.1 mt -147.69 -62.27 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.954 0.407 . . . . 0.0 111.058 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.8 tpp180 61.28 113.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.915 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -91.51 163.09 29.8 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.993 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -50.49 -179.66 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.693 2.262 . . . . 0.0 112.507 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -68.14 109.09 3.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.002 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.39 18.16 53.43 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.5 mmt -114.49 123.03 48.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 110.881 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.84 134.81 53.52 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.98 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.89 146.57 41.77 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD21 ' CG1' ' A' ' 20' ' ' VAL . 13.4 mt -108.07 176.24 5.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.953 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.83 -31.12 69.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -67.13 -35.5 79.85 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.11 -29.41 4.35 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.523 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -70.09 169.1 14.17 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.815 0.341 . . . . 0.0 110.886 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -119.85 109.84 16.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.991 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.675 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.4 p -100.07 156.35 4.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.005 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.446 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -74.4 143.19 44.89 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.062 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 22' ' ' THR . 3.2 t -64.0 81.41 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.874 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.31 41.74 2.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.409 ' N ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -56.75 -60.9 7.99 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.079 179.987 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.409 ' HD2' ' N ' ' A' ' 24' ' ' GLU . 54.5 Cg_endo -69.66 111.81 2.89 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.565 2.177 . . . . 0.0 112.351 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -52.1 -176.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.461 2.108 . . . . 0.0 112.278 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -81.17 174.48 11.52 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.0 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -58.89 161.24 9.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.963 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -49.91 -60.87 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.548 2.165 . . . . 0.0 112.508 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 14.8 p30 -143.67 28.5 1.44 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.002 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.2 m 57.91 70.89 0.62 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.225 -0.893 . . . . 0.0 110.899 179.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.851 0.358 . . . . 0.0 111.146 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.2 p -60.68 158.31 2.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.13 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.487 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.7 pt20 -59.37 102.56 0.14 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.571 HG22 ' O ' ' A' ' 4' ' ' ILE . 3.7 mt -124.19 42.53 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.048 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.549 ' H ' HD12 ' A' ' 5' ' ' LEU . 2.2 mp -80.2 -63.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.765 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 35.0 ttp180 57.42 91.97 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.115 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 1.2 m -142.34 64.89 17.2 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.888 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 24.4 Cg_exo -63.47 -158.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.645 2.23 . . . . 0.0 112.25 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 32.2 p-10 -52.9 131.6 35.97 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.043 179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 113.48 -29.06 8.15 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.266 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -130.18 140.86 50.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.831 0.348 . . . . 0.0 110.739 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -142.0 157.27 45.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.245 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.516 ' O ' HD23 ' A' ' 14' ' ' LEU . 38.7 mtm -59.77 164.48 3.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.863 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.852 HD11 ' CG1' ' A' ' 20' ' ' VAL . 38.0 mt -133.68 176.02 8.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.84 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.5 mtt180 -58.33 -30.49 66.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.985 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.24 -37.11 77.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.877 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 131.13 -30.79 3.28 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.572 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -84.57 162.1 19.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.799 0.333 . . . . 0.0 110.861 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.428 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 8.1 p -107.88 119.12 38.55 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.972 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.852 ' CG1' HD11 ' A' ' 14' ' ' LEU . 11.1 p -100.21 158.27 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.114 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -89.69 104.38 16.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.034 179.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -57.78 93.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.951 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -98.57 32.01 2.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.925 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -66.54 144.55 98.7 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.755 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.72 110.47 2.9 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.511 2.14 . . . . 0.0 112.392 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -74.49 -168.71 0.51 Allowed 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 122.406 2.071 . . . . 0.0 112.228 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -64.98 86.13 0.05 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.818 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -58.03 164.53 3.32 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.977 -179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -51.99 -61.63 0.48 Allowed 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.65 2.233 . . . . 0.0 112.327 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.1 t70 57.66 78.09 0.25 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.831 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.439 ' O ' ' CG ' ' A' ' 32' ' ' TYR . 0.9 OUTLIER -60.25 122.6 14.9 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.907 -179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.439 ' CG ' ' O ' ' A' ' 31' ' ' SER . 47.7 p90 . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.392 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 77.9 p . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.838 0.351 . . . . 0.0 111.157 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG12 ' N ' ' A' ' 3' ' ' GLN . 17.4 t -86.91 159.3 3.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.468 ' N ' HG12 ' A' ' 2' ' ' VAL . 0.6 OUTLIER -105.84 -168.25 1.42 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.008 -179.955 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 2.2 pt -66.46 -14.61 17.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.564 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD12 ' SD ' ' A' ' 13' ' ' MET . 7.0 tp -82.7 57.89 4.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.893 0.378 . . . . 0.0 110.883 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.461 ' CD ' HG11 ' A' ' 2' ' ' VAL . 5.8 mmt180 -96.9 32.0 2.23 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.02 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 90.2 m -116.41 79.9 9.55 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.853 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.87 -165.63 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.595 2.197 . . . . 0.0 112.723 -179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -60.49 106.49 0.55 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.844 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.57 -25.4 2.59 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.573 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.29 137.41 44.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.922 0.391 . . . . 0.0 110.903 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 70.3 mm-40 -123.1 135.59 54.44 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.839 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.462 ' SD ' HD12 ' A' ' 5' ' ' LEU . 0.6 OUTLIER -82.34 147.73 28.68 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 17.2 mt -105.2 172.9 6.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.981 -179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.7 mmp_? -60.3 -32.67 71.43 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.979 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -61.79 -36.15 80.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.912 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 127.92 -31.4 3.71 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.478 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 24.2 mp0 -68.64 168.1 13.79 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.93 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -127.49 122.47 33.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 10.8 p -100.12 132.14 46.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.059 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -84.43 121.88 28.18 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.054 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.26 39.98 0.99 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.274 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.3 t -160.16 31.47 0.17 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.859 0.361 . . . . 0.0 110.948 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -74.75 -60.9 1.18 Allowed Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.974 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 61.2 Cg_endo -73.4 153.43 50.3 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.478 2.119 . . . . 0.0 112.321 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -71.55 179.33 4.73 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.58 2.187 . . . . 0.0 112.246 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -163.01 34.3 0.1 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.897 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.9 OUTLIER -83.88 -52.51 0.57 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.008 179.971 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.416 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.4 Cg_exo -54.47 -170.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.492 2.128 . . . . 0.0 112.27 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -159.61 -44.98 0.05 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.4 m -162.73 115.15 1.61 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.954 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.6 p90 . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.884 -179.973 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.733 0.302 . . . . 0.0 111.233 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 29.2 t -86.3 145.58 7.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.027 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.31 101.13 13.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.965 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.786 HG23 HD23 ' A' ' 5' ' ' LEU . 8.5 tp -110.59 -24.91 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.217 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.786 HD23 HG23 ' A' ' 4' ' ' ILE . 0.4 OUTLIER -119.37 73.45 0.95 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.799 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 19.3 ttm180 -68.19 69.14 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.107 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -157.37 82.1 3.12 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.82 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -59.51 -165.8 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.518 2.145 . . . . 0.0 112.628 -179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -64.27 126.76 28.81 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.854 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 99.92 -21.78 43.26 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.494 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 85.6 mtp -103.79 113.02 26.23 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.857 0.36 . . . . 0.0 110.789 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.83 140.5 43.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.87 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.4 152.51 44.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.943 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.612 HD21 ' CG1' ' A' ' 20' ' ' VAL . 10.8 mt -104.08 166.75 10.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.831 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.54 -31.34 67.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.911 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.52 -32.02 58.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.849 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.69 -25.94 4.13 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.57 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 9.0 mm100 -61.04 170.59 1.53 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.827 0.346 . . . . 0.0 111.097 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -113.87 110.96 20.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.612 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.8 p -100.12 145.11 11.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.074 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -99.7 132.41 45.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.07 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -88.17 80.23 7.67 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.02 68.17 0.66 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.736 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -55.89 129.05 71.66 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.937 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_exo -46.65 146.67 5.16 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.6 2.2 . . . . 0.0 112.43 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.81 -167.92 0.42 Allowed 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.469 2.112 . . . . 0.0 112.292 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -61.93 -178.29 0.15 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.891 179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.02 148.28 37.15 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HB3' ' CE2' ' A' ' 32' ' ' TYR . 57.7 Cg_endo -71.52 -173.99 1.13 Allowed 'Trans proline' 0 C--N 1.344 0.291 0 C-N-CA 122.58 2.187 . . . . 0.0 112.254 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -168.19 -43.33 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.991 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.3 t -102.8 -36.77 8.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.96 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 29' ' ' PRO . 49.1 p90 . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.97 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.754 0.312 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.491 HG12 ' N ' ' A' ' 3' ' ' GLN . 73.0 t 59.36 158.67 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.054 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.491 ' N ' HG12 ' A' ' 2' ' ' VAL . 8.8 mp0 -90.85 -170.15 2.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.913 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.506 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -138.85 55.31 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.031 -179.925 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -97.99 30.38 3.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.044 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 31.5 ttm180 58.79 163.01 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.439 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 25.0 m -89.04 101.99 3.63 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.83 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 7' ' ' CYS . 11.4 Cg_endo -56.61 -165.77 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.377 2.051 . . . . 0.0 112.631 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -61.99 120.66 11.23 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.858 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 117.67 -25.34 8.58 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.538 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.9 mtt -118.89 132.37 56.1 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.0 110.835 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 13.0 mt-30 -136.4 143.01 43.74 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.957 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.5 ttp -86.22 129.33 34.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.899 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.483 HD21 ' CG1' ' A' ' 20' ' ' VAL . 14.4 mt -87.72 177.94 6.88 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.949 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 13.2 ptp180 -60.55 -30.63 69.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.01 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -67.05 -34.77 78.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 123.75 -28.17 5.51 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.474 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -70.55 144.82 51.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.927 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -99.06 107.19 19.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.839 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG1' HD21 ' A' ' 14' ' ' LEU . 12.5 p -99.94 157.9 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.168 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.48 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -87.94 149.01 24.31 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.157 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -59.96 87.63 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.87 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -98.79 31.85 2.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.905 179.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.4 143.53 88.03 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.872 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.12 110.38 3.06 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.599 2.199 . . . . 0.0 112.398 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -73.78 139.12 27.28 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.446 2.097 . . . . 0.0 112.195 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -176.58 40.94 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.98 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.406 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.8 OUTLIER -68.84 -52.77 16.61 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.886 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 50.0 Cg_exo -53.51 160.44 5.16 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.517 2.145 . . . . 0.0 112.228 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -176.75 -69.14 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.928 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -178.45 -39.02 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.893 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.245 -0.883 . . . . 0.0 110.958 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.39 0 CA-C-O 120.918 0.39 . . . . 0.0 111.147 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 ' O ' HG12 ' A' ' 2' ' ' VAL . 22.2 t -88.02 54.6 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.019 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.56 -178.91 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.94 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.561 HG23 ' O ' ' A' ' 4' ' ' ILE . 1.0 OUTLIER -170.61 60.43 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.977 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.62 HD12 ' N ' ' A' ' 6' ' ' ARG . 0.3 OUTLIER -58.75 -20.36 48.73 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.245 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.62 ' N ' HD12 ' A' ' 5' ' ' LEU . 13.1 tpt180 -71.42 105.27 3.49 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.744 0.307 . . . . 0.0 110.938 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -115.74 85.32 14.01 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.822 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.0 -178.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.649 2.233 . . . . 0.0 112.44 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.8 140.86 34.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.966 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.88 -25.98 25.26 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.6 ttt -136.26 125.55 24.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.782 0.325 . . . . 0.0 110.869 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -137.21 178.79 6.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.942 -179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 9.8 mmt -80.08 138.2 36.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.969 HD22 HG23 ' A' ' 20' ' ' VAL . 1.2 pt? -104.72 -176.47 3.09 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.03 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 10.5 mmt180 -59.1 -38.26 79.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.085 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.568 ' HB2' HD11 ' A' ' 14' ' ' LEU . 3.5 m -65.41 -31.59 72.76 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.029 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 120.39 -33.27 4.56 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.409 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.55 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.87 -166.9 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.699 0.285 . . . . 0.0 110.821 179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -122.56 102.61 8.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.94 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.969 HG23 HD22 ' A' ' 14' ' ' LEU . 39.3 t -100.16 158.36 3.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.135 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.491 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -70.66 100.03 1.78 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.984 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.7 100.53 1.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.903 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.9 t -99.97 30.26 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.958 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.414 ' CB ' ' HD3' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -85.97 -62.51 0.24 Allowed Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.039 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.414 ' HD3' ' CB ' ' A' ' 24' ' ' GLU . 74.2 Cg_endo -77.09 153.42 32.17 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.395 2.063 . . . . 0.0 112.323 -179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -70.62 -175.74 1.47 Allowed 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.44 2.093 . . . . 0.0 112.314 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -102.64 -177.03 3.27 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.851 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' N ' ' HD2' ' A' ' 29' ' ' PRO . 4.4 m-20 -55.27 -60.5 8.12 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.098 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.401 ' HD2' ' N ' ' A' ' 28' ' ' ASP . 58.5 Cg_endo -71.9 -168.27 0.36 Allowed 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.518 2.145 . . . . 0.0 112.262 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -173.03 -41.43 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.968 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.8 m -178.36 -38.99 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.903 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 54.3 p90 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.878 179.996 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.841 0.353 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 59.7 t 52.21 73.54 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.247 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -93.32 -168.45 1.92 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.894 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.593 HG22 ' O ' ' A' ' 4' ' ' ILE . 2.3 mt -98.17 32.29 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 5' ' ' LEU . 0.9 OUTLIER -178.34 100.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.875 -179.995 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.3 ttm180 -78.45 61.02 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.003 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.2 m -154.38 86.84 3.59 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.747 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -56.13 -164.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.554 2.169 . . . . 0.0 112.516 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -59.18 138.24 57.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.944 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 88.75 -9.33 76.67 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.875 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.3 mtt -132.86 139.13 47.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.957 0.408 . . . . 0.0 110.885 179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 3.2 mm100 -152.63 146.17 24.96 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 mtm -82.91 137.77 34.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.978 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.609 HD11 HG21 ' A' ' 20' ' ' VAL . 13.4 mt -101.97 -177.28 3.37 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.852 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -62.13 -32.8 73.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.926 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -65.15 -30.91 71.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.886 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.25 -28.4 7.24 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.489 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 17.6 mt-30 -76.77 148.03 36.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.82 0.343 . . . . 0.0 110.844 -179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 7.1 t -94.17 112.23 24.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.945 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.609 HG21 HD11 ' A' ' 14' ' ' LEU . 21.4 t -99.98 158.83 3.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.153 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.483 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -68.63 105.46 2.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.086 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.69 89.83 5.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.706 -179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 9.9 t -125.77 44.09 2.92 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.839 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -56.69 109.07 1.45 Allowed Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -73.6 153.1 49.04 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.39 2.06 . . . . 0.0 112.307 -179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -72.45 -167.94 0.36 Allowed 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.555 2.17 . . . . 0.0 112.276 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -58.78 171.64 0.63 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.805 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.452 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 1.5 m-20 -59.49 -59.03 15.17 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.992 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.452 ' HD3' ' CB ' ' A' ' 28' ' ' ASP . 85.3 Cg_exo -46.6 171.05 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.407 2.071 . . . . 0.0 112.412 179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -148.38 -70.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.947 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.1 78.1 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.89 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 4.4 p90 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.28 -0.866 . . . . 0.0 110.907 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.7 m . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 120.827 0.346 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 23.8 t -80.94 149.05 5.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.068 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -127.79 163.09 25.12 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 7.1 tp -63.96 -28.49 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.211 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 4.5 mp -61.4 -79.95 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 21.2 ttt-85 58.43 163.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.3 m -79.77 112.72 31.81 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.967 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_exo -50.3 -178.72 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.554 2.169 . . . . 0.0 112.479 179.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -58.64 132.3 53.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.894 179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.96 -22.52 33.24 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.521 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.695 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 mtt -111.87 114.77 27.92 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -118.45 133.98 55.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.848 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.9 ptt? -79.62 138.43 37.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.917 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.684 HD11 ' CG2' ' A' ' 20' ' ' VAL . 4.1 mt -82.14 175.62 10.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -59.1 -30.38 68.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.947 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 2.3 m -70.17 -35.54 74.06 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.018 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 128.7 -27.74 4.32 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.503 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.39 145.61 37.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.822 0.344 . . . . 0.0 110.952 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.32 109.47 22.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.938 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.684 ' CG2' HD11 ' A' ' 14' ' ' LEU . 22.7 t -100.03 129.15 51.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.051 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -88.42 163.26 16.06 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 9.6 t -90.21 45.34 1.26 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.447 HG23 ' O ' ' A' ' 23' ' ' THR . 7.3 t -129.27 66.93 1.44 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.659 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.415 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.6 OUTLIER -50.49 176.38 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.178 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.415 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 77.4 Cg_exo -50.14 -179.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.626 2.218 . . . . 0.0 112.472 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -50.68 174.94 0.05 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.559 2.173 . . . . 0.0 112.403 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 9.1 m-85 -106.32 171.04 7.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.886 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -58.51 147.65 68.49 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.888 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.73 -47.84 1.2 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.574 2.183 . . . . 0.0 112.28 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.0 p30 43.29 32.85 0.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.427 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 64.81 -78.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 -179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 12.4 p90 . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.919 179.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 CA-C-O 120.805 0.336 . . . . 0.0 111.198 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -74.6 119.74 22.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.012 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -88.01 168.56 12.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.914 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 tt -94.42 -26.5 4.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.134 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.26 95.57 0.76 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.784 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -51.98 173.86 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.023 -179.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 52.1 m -125.76 74.8 70.6 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.968 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.23 -175.44 0.04 OUTLIER 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.592 2.195 . . . . 0.0 112.343 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.51 112.47 1.28 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 136.09 -27.99 2.97 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.39 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.87 138.9 51.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.948 0.404 . . . . 0.0 110.783 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -131.81 141.42 49.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.964 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 6.5 ttp -77.22 139.5 39.89 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.852 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.536 HD21 ' CG1' ' A' ' 20' ' ' VAL . 36.7 mt -99.21 175.54 5.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.82 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.1 mtm180 -58.9 -31.03 68.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.941 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 1.3 m -70.69 -35.09 72.61 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.886 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 129.43 -31.56 3.4 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.52 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.77 162.37 13.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.867 0.365 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.6 t -117.21 104.37 11.12 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.93 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' CG1' HD21 ' A' ' 14' ' ' LEU . 11.4 p -99.98 158.27 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.159 179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.485 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -68.65 136.51 53.07 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.03 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -90.18 46.91 1.39 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.002 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.1 t -160.11 43.59 0.21 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.412 ' CB ' ' HD3' ' A' ' 25' ' ' PRO . 1.3 mt-10 -80.42 -52.76 0.93 Allowed Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.45 ' N ' ' CD ' ' A' ' 26' ' ' PRO . 31.2 Cg_exo -57.74 -47.88 19.23 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.337 2.025 . . . . 0.0 112.361 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.45 ' CD ' ' N ' ' A' ' 25' ' ' PRO . 86.9 Cg_endo -82.75 -167.5 0.48 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.569 2.179 . . . . 0.0 112.272 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.5 t80 58.69 108.14 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 179.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -118.47 173.94 3.02 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.825 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.39 -175.06 0.02 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.564 2.176 . . . . 0.0 112.299 179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -112.85 -79.32 0.58 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.959 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 63.8 -79.71 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.042 -179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.5 t80 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.203 -0.903 . . . . 0.0 110.91 179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.839 0.352 . . . . 0.0 111.182 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 2' ' ' VAL . 9.8 p -73.4 64.72 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.027 0.442 . . . . 0.0 111.031 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -75.08 108.93 8.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.964 179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.806 HD12 ' CD1' ' A' ' 5' ' ' LEU . 1.1 pp -112.82 33.06 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.025 0.44 . . . . 0.0 110.993 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.806 ' CD1' HD12 ' A' ' 4' ' ' ILE . 1.8 mp -140.33 -46.74 0.42 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.975 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.32 152.53 40.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.937 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.7 m -120.58 81.52 32.21 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.888 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.89 -160.89 0.01 OUTLIER 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.593 2.195 . . . . 0.0 112.395 -179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -54.69 127.28 27.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.985 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.53 -27.68 7.87 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.386 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.4 mtt -134.34 105.03 6.4 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.78 0.324 . . . . 0.0 110.843 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . 0.753 ' NE2' HG21 ' A' ' 22' ' ' THR . 0.0 OUTLIER -93.46 125.09 37.88 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.823 -179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 78.0 mtp -66.63 157.79 31.61 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.95 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.792 HD11 HG23 ' A' ' 20' ' ' VAL . 7.3 mt -122.69 -179.71 4.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.93 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 3.0 tpm_? -60.29 -32.42 71.18 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.922 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -69.64 -32.28 70.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.999 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 125.57 -32.26 3.94 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.45 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 8.6 mt-30 -76.91 154.84 33.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.777 0.322 . . . . 0.0 110.885 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.7 p -114.43 130.79 56.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.978 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.792 HG23 HD11 ' A' ' 14' ' ' LEU . 30.8 t -99.81 158.17 3.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.143 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -64.57 105.16 0.9 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.059 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.753 HG21 ' NE2' ' A' ' 12' ' ' GLN . 9.0 t -90.35 37.94 0.92 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.179 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.3 m -159.97 71.3 0.47 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.821 0.343 . . . . 0.0 110.791 179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -100.09 105.62 36.57 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.032 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.486 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 52.6 Cg_exo -52.88 -47.0 29.8 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.429 2.086 . . . . 0.0 112.61 179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 78.3 Cg_endo -77.79 145.4 22.73 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.243 1.962 . . . . 0.0 112.46 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -176.78 179.52 1.08 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.958 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -118.77 63.75 5.96 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.814 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -71.49 -168.02 0.33 Allowed 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.602 2.202 . . . . 0.0 112.316 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 31.5 p30 -120.13 30.48 6.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.922 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.93 -170.05 1.51 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.928 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.228 -0.892 . . . . 0.0 110.835 179.959 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.5 p . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.768 0.318 . . . . 0.0 111.281 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -86.36 125.0 40.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.116 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -70.63 127.93 34.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tt -109.86 -24.02 4.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.178 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.625 HD12 ' HB2' ' A' ' 7' ' ' CYS . 0.1 OUTLIER -60.41 -45.66 92.8 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.91 -179.962 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.5 tpp180 56.28 55.54 6.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.997 179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.625 ' HB2' HD12 ' A' ' 5' ' ' LEU . 93.3 m -151.66 84.23 5.12 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.867 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -52.54 -179.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.592 2.194 . . . . 0.0 112.223 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.69 116.64 4.18 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.01 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 125.92 -28.2 4.95 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.441 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.31 130.67 56.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.81 0.338 . . . . 0.0 110.826 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 2.6 tm0? -125.4 144.41 50.53 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.909 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.26 147.75 28.76 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.857 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' CD2' HG23 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -107.36 179.66 4.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.888 -179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 19.0 mtm180 -59.73 -34.95 73.61 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.013 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.668 ' HB2' HD12 ' A' ' 14' ' ' LEU . 1.2 m -64.13 -30.84 71.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.799 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 119.99 -28.35 6.41 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.478 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -66.99 171.67 5.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.802 0.334 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.87 112.58 16.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.67 HG23 ' CD2' ' A' ' 14' ' ' LEU . 30.3 t -99.97 137.73 26.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.027 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -87.24 128.09 35.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.15 179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -65.48 99.74 0.45 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.4 m -140.03 31.06 1.99 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.859 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.458 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 3.2 mt-10 -72.39 -65.02 0.84 Allowed Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.094 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 2.6 Cg_endo -42.62 -57.23 1.75 Allowed 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.92 2.413 . . . . 0.0 112.722 -179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HD2' ' N ' ' A' ' 25' ' ' PRO . 41.7 Cg_endo -67.34 -171.03 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.365 2.043 . . . . 0.0 112.314 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.82 -174.37 4.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.805 -179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.433 ' CB ' ' CD ' ' A' ' 29' ' ' PRO . 3.5 m-20 -68.38 -62.55 2.98 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.009 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 28' ' ' ASP . 18.0 Cg_endo -60.43 -75.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.413 2.075 . . . . 0.0 112.314 -179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -177.81 -70.98 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.977 0.418 . . . . 0.0 110.907 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.4 p -176.47 -78.06 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.868 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 2.4 t80 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.263 -0.875 . . . . 0.0 110.84 -179.974 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.879 0.371 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 3' ' ' GLN . 11.3 p -67.93 159.15 5.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.142 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.498 ' N ' HG22 ' A' ' 2' ' ' VAL . 0.9 OUTLIER -54.21 -177.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.076 -179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.512 HG23 ' O ' ' A' ' 4' ' ' ILE . 2.4 tt -142.83 58.5 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.915 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.689 ' H ' HD13 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -65.94 -13.62 60.08 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.644 -179.673 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.401 ' N ' HD22 ' A' ' 5' ' ' LEU . 0.0 OUTLIER -174.59 105.98 0.1 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.807 0.337 . . . . 0.0 111.245 -179.997 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.407 ' N ' ' HD3' ' A' ' 8' ' ' PRO . 13.7 m -158.99 61.61 1.92 Allowed Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.677 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.407 ' HD3' ' N ' ' A' ' 7' ' ' CYS . 65.9 Cg_exo -51.34 -179.19 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.565 2.176 . . . . 0.0 112.393 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -60.57 127.91 34.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.845 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.84 -28.27 14.63 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.403 -179.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.596 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 1.7 tpp -94.33 96.33 9.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.846 0.355 . . . . 0.0 110.764 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 8.8 mp0 -94.27 147.16 23.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.915 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 13.1 mtt -67.49 154.47 41.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.978 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.651 HD11 ' HB ' ' A' ' 20' ' ' VAL . 90.1 mt -108.74 171.92 7.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.89 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ptp85 -58.45 -31.96 68.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.872 179.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.4 -30.94 53.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.822 179.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . 0.453 ' O ' HG11 ' A' ' 2' ' ' VAL . . . 129.4 -27.02 4.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.602 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -58.61 175.29 0.26 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.843 0.354 . . . . 0.0 111.006 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -118.32 101.54 8.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.805 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.651 ' HB ' HD11 ' A' ' 14' ' ' LEU . 10.6 p -79.89 134.26 27.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.157 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.596 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -79.84 79.67 6.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.189 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.74 82.78 7.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -91.04 59.9 4.17 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.883 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 -100.13 94.22 3.11 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.931 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -67.33 171.6 11.39 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.454 2.103 . . . . 0.0 112.265 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -69.59 -168.8 0.28 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.566 2.177 . . . . 0.0 112.169 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.99 142.96 52.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.801 -179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -58.58 155.12 30.91 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.16 99.05 1.14 Allowed 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.668 2.245 . . . . 0.0 112.353 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -96.51 62.06 2.0 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.854 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.32 32.47 2.21 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.036 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.7 t80 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.278 -0.868 . . . . 0.0 111.009 179.971 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.363 0 CA-C-O 120.799 0.333 . . . . 0.0 111.205 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.58 ' O ' HG12 ' A' ' 2' ' ' VAL . 16.8 t -144.92 33.24 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.069 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 mt-30 -60.27 -169.95 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.975 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.591 HG22 ' O ' ' A' ' 4' ' ' ILE . 2.2 mt -113.52 31.85 1.45 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.027 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -157.98 46.2 0.35 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.852 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -174.07 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.838 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -136.2 66.64 60.39 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.06 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -72.4 -157.71 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.74 2.293 . . . . 0.0 111.972 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -60.42 87.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.75 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 155.09 -24.39 0.6 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.442 -179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 12.4 mtt -137.32 136.11 37.69 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.796 0.331 . . . . 0.0 110.786 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -114.38 -164.96 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.718 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.3 ttp -100.02 142.93 30.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.961 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.737 HD12 ' CB ' ' A' ' 18' ' ' GLN . 21.2 mt -79.89 164.73 23.33 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.969 0.414 . . . . 0.0 110.823 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.3 -24.54 29.11 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.913 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -93.48 -30.96 14.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.885 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.78 -22.28 3.15 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.759 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.737 ' CB ' HD12 ' A' ' 14' ' ' LEU . 1.7 mp0 -55.86 -172.16 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.782 0.325 . . . . 0.0 110.992 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -107.94 117.38 33.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.895 0.379 . . . . 0.0 111.166 -179.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 21' ' ' ALA . 11.5 p -100.18 159.09 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.995 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' N ' HG22 ' A' ' 20' ' ' VAL . . . -99.82 141.87 32.06 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.965 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 92.4 m -58.36 91.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.024 -179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.23 30.69 0.69 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.788 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -76.57 -60.9 0.82 Allowed Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.008 -179.917 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 26' ' ' PRO . 61.4 Cg_endo -73.36 110.22 3.01 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.48 2.12 . . . . 0.0 112.377 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 25' ' ' PRO . 45.2 Cg_endo -68.25 -167.24 0.17 Allowed 'Trans proline' 0 C--N 1.348 0.522 0 C-N-CA 122.325 2.017 . . . . 0.0 112.307 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 13.5 m-85 -66.42 75.52 0.1 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.958 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -59.21 110.21 2.51 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.91 91.63 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.409 2.072 . . . . 0.0 112.437 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -86.33 -36.64 19.14 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.947 -179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m -178.15 -76.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 25.4 p90 . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.346 -0.835 . . . . 0.0 110.958 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.486 1.33 0 CA-C-O 120.75 0.31 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 2' ' ' VAL . 10.2 p -76.05 109.6 10.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.125 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.482 ' OE1' HD11 ' A' ' 5' ' ' LEU . 2.9 tt0 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.911 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.482 HD12 ' HG ' ' A' ' 5' ' ' LEU . 1.2 pp -104.19 30.87 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.092 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.794 HD13 ' NE2' ' A' ' 18' ' ' GLN . 1.4 pp -158.94 31.12 0.21 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.831 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 2.4 mmt180 -59.21 -174.66 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.813 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m -122.25 77.33 43.32 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.078 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -64.88 175.93 3.37 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.77 2.313 . . . . 0.0 112.07 -179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -68.93 81.43 0.3 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.729 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.519 ' O ' HG22 ' A' ' 22' ' ' THR . . . 153.29 -21.77 0.75 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.627 -179.905 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.4 mtm -100.1 119.21 37.95 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.817 0.341 . . . . 0.0 110.626 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -101.2 150.57 22.82 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.932 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.2 mtm -65.21 153.3 41.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.832 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.942 HD22 HG23 ' A' ' 20' ' ' VAL . 1.5 pt? -121.46 -176.68 3.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.037 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.3 mtp-105 -59.32 -41.57 89.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.142 -179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.532 ' HB2' HD11 ' A' ' 14' ' ' LEU . 2.8 m -60.16 -31.2 69.88 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.885 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 121.46 -36.18 3.36 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.362 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.794 ' NE2' HD13 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -63.29 -166.75 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.687 0.28 . . . . 0.0 110.653 179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 1.1 m -126.68 117.06 21.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.043 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.942 HG23 HD22 ' A' ' 14' ' ' LEU . 21.4 t -100.01 156.82 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.095 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.438 ' N ' HG12 ' A' ' 20' ' ' VAL . . . -70.13 134.84 48.57 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.566 HG23 ' O ' ' A' ' 22' ' ' THR . 10.1 t -66.98 99.59 0.66 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.945 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -104.57 29.95 5.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.848 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 4.0 mt-10 -82.9 148.65 57.7 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.864 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -72.87 112.01 3.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.577 2.184 . . . . 0.0 112.318 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -53.09 -174.16 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.372 2.048 . . . . 0.0 112.306 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 3.4 t80 -98.07 29.71 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.976 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' CB ' ' HD3' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -89.59 -62.72 0.21 Allowed Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.067 -179.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 28' ' ' ASP . 75.2 Cg_endo -77.45 169.96 20.19 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.322 2.014 . . . . 0.0 112.304 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -177.92 -61.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.88 -39.35 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.937 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.207 -0.901 . . . . 0.0 110.937 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.6 t . . . . . 0 N--CA 1.486 1.352 0 CA-C-O 120.993 0.425 . . . . 0.0 111.243 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.4 m -63.83 128.03 25.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.15 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.8 mp0 -60.16 -177.95 0.07 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.971 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -103.43 31.28 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.179 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.9 tp -159.83 28.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.03 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.86 161.58 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.008 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.431 ' CB ' ' HB2' ' A' ' 11' ' ' MET . 87.3 m -94.81 153.49 40.02 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.857 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -50.23 179.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.778 2.319 . . . . 0.0 112.622 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -60.23 136.07 57.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.82 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 92.26 -5.93 78.23 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.507 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.437 ' SD ' ' HB2' ' A' ' 21' ' ' ALA . 31.6 mtt -112.73 130.56 56.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.779 0.324 . . . . 0.0 110.929 -179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -109.8 91.71 3.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.027 -179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.41 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 2.2 ttt -86.66 156.28 20.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.863 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.844 HD12 ' HB2' ' A' ' 16' ' ' SER . 0.2 OUTLIER -116.75 161.39 19.32 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.864 -179.945 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 12.8 ttp85 -55.94 -30.49 61.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.987 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.844 ' HB2' HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -60.56 -34.72 74.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.69 179.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 130.07 -27.14 4.1 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.555 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLN . . . . . 0.609 ' HB2' HD11 ' A' ' 14' ' ' LEU . 93.1 mt-30 -58.86 144.64 43.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.816 0.341 . . . . 0.0 110.923 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.41 ' HA ' ' HA ' ' A' ' 13' ' ' MET . 42.4 t -119.4 112.58 19.58 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.868 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.464 ' O ' HG12 ' A' ' 20' ' ' VAL . 26.8 t -85.08 57.1 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.437 ' HB2' ' SD ' ' A' ' 11' ' ' MET . . . -63.08 127.11 29.72 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.092 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 1.3 m -90.36 26.99 1.78 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.226 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 t -160.22 35.35 0.17 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.695 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.411 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 2.4 mt-10 -55.79 -61.02 7.03 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.318 -179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 24' ' ' GLU . 56.2 Cg_endo -70.86 110.94 2.91 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.429 2.086 . . . . 0.0 112.398 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -77.64 130.22 10.56 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.478 2.118 . . . . 0.0 112.214 179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.18 97.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.01 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.5 OUTLIER -61.15 -52.5 71.04 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.856 179.886 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 28' ' ' ASP . 52.2 Cg_exo -52.82 89.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.569 2.179 . . . . 0.0 112.219 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -98.9 36.27 1.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.2 t -162.86 35.94 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.933 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 35.1 t80 . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.188 -0.91 . . . . 0.0 110.954 179.96 . . . . . . . . 0 0 . 1 stop_ save_